DMAC vs UAL · $157.4M cap vs P/E 10, rev $57.06B
DiaMedica Therapeutics Inc (DMAC) versus United Airlines Holdings Inc (UAL) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
United Airlines Holdings Inc (UAL) is a airlines company listed on NASDAQ. It is led by Scott Kirby.
DMAC does not have a complete income-statement cache yet.
Latest reported UAL revenue for 2024-12-31 was $57.06B. Net income was $3.15B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. UAL currently screens at market cap $37.59B and trailing P/E 10.4.
DMAC currently screens at market cap $157.4M. UAL currently screens at market cap $37.59B and trailing P/E 10.4.
Not investment advice. Open the DMAC and UAL stock pages for the full models.
Not investment advice.